RenovoRx Continues with Strong Momentum and Reaches Milestone of 100th Patient Enrolled in its Phase III TIGeR-PaC Clinical Trial,

RenovoRx, an innovator in targeted cancer therapy, today announced it has reached an important milestone with continued momentum and the enrollment of the 100 th patient in its phase III TIGeR-PaC …, RenovoRx, an innovator in targeted cancer therapy, today announced it has reached an important milestone with continued momentum and the enrollment of the 100 th patient in its phase III TIGeR-PaC …, Read More

Scroll to Top